Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD)

Trial Profile

Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 May 2016

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Acronyms Shield-CAD
  • Most Recent Events

    • 14 Aug 2012 New trial record
    • 10 Aug 2012 Planned End Date changed from 30 Sep 2014 to 31 Oct 2014 as reported by University Hospital Medical Information Network - Japan record (UMIN000008671).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top